MedPath

上海博莱科信谊药业有限责任公司

Ownership
-
Established
2001-12-19
Employees
-
Market Cap
-
Website
www.braccosine.com

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

34

NMPA:34

Drug Approvals

钆贝葡胺注射液

Product Name
莫迪司
Approval Number
国药准字H20054703
Approval Date
Feb 21, 2024
NMPA

Iopamidol Injection

Product Name
典比乐
Approval Number
国药准字H20053385
Approval Date
Feb 21, 2024
NMPA

Iopamidol Injection

Product Name
碘帕醇注射液
Approval Number
国药准字H20073014
Approval Date
Feb 21, 2024
NMPA

Iopamidol Injection

Product Name
典比乐
Approval Number
国药准字H20053383
Approval Date
Feb 21, 2024
NMPA

Iopamidol Injection

Product Name
典比乐
Approval Number
国药准字H20053384
Approval Date
Feb 21, 2024
NMPA

Iopamidol Injection

Product Name
典比乐
Approval Number
国药准字H20053387
Approval Date
Feb 21, 2024
NMPA

钆贝葡胺注射液

Product Name
莫迪司
Approval Number
国药准字H20054702
Approval Date
Feb 21, 2024
NMPA

Iopamidol Injection

Product Name
典比乐
Approval Number
国药准字H20053388
Approval Date
Feb 21, 2024
NMPA

钆贝葡胺注射液

Product Name
莫迪司
Approval Number
国药准字H20054701
Approval Date
Feb 21, 2024
NMPA

Iopamidol Injection

Product Name
碘帕醇注射液
Approval Number
国药准字H20073013
Approval Date
Feb 21, 2024
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • Next

Clinical Trials

No trials found

News

No news found
© Copyright 2025. All Rights Reserved by MedPath
HomeTerms & ConditionsPrivacy Policy